Rivastigmine Tartrate
Average across 40 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Alembic Pharmaceuticals Limited | generic | 40 | SUPPLYING |
| Dr.Reddy's laboratories Limited | unknown | 16 | SUPPLYING |
| Macleods Pharmaceuticals Limited | generic | 16 | SUPPLYING |
| SUN PHARMACEUTICAL INDUSTRIES, INC. | generic | 12 | SUPPLYING |
| Modavar Pharmaceuticals LLC | unknown | 8 | SUPPLYING |
| Aurobindo Pharma Limited | generic | 8 | SUPPLYING |
| Cadila Pharmaceuticals Limited | unknown | 8 | SUPPLYING |
| Nivagen Pharmaceuticals, Inc. | unknown | 8 | SUPPLYING |
| Chartwell RX, LLC | generic | 4 | SUPPLYING |
| American Health Packaging | repackager | 1 | SUPPLYING |
| Major Pharmaceuticals | relabeler | 1 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Cross-contamination with other products -Related Substances test for Rivastigmine Tartrate Capsules USP, 1.5 mg showed a peak for Ranitidine. — Recalling firm: Dr. Reddy's Laboratories, Inc. — U.S. nationwide
Failed Dissolution Specifications — Recalling firm: Dr. Reddy's Laboratories, Inc. — Nationwide
